CMML: GM-CSF inhibitor lenzilumab shows early promiseJune 20, 2023AMLMyelodysplastic SyndromeMixed Topics
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Lung CancerBreast CancerGenitourinary CancerMixed TopicsMelanomaAMLBusiness of Medicine
ASCO honors Hagop Kantarjian, MD, for leukemia researchMay 16, 2023AMLBusiness of MedicineMixed TopicsMyelodysplastic SyndromeHematologic Malignancies
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Lung CancerOncologyDiversity in MedicineGeriatricsBreast CancerMixed TopicsGenitourinary Cancer
AFib risk with cancer drugs underestimatedApril 12, 2023Breast CancerLung CancerImmuno-oncologyAMLMultiple Myeloma
‘Extremely exciting’ study results guide MM treatment optionsJune 6, 2022Multiple MyelomaAMLMyelodysplastic SyndromeMixed TopicsHematologic MalignanciesOncology
Talk early to patients with high-risk AML about end-of-life decisionsDecember 12, 2021AMLHematologic Malignancies
Myeloid patients respond robustly to Moderna COVID vaccineDecember 12, 2021COVID-19 UpdatesAMLMyelodysplastic Syndrome
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferralsDecember 11, 2021COVID-19 UpdatesMyelodysplastic SyndromeAML
